Looking into Ocular Challenges: Mitigating and Managing ADC Ocular Surface Toxicity

Time: 11:30 am
day: Conference Day 1


  • Overview of ocular surface toxicities associated with ADCs
  • Case study: clinical presentation and management of corneal adverse events associated with a maytansine ADC
  • Evaluating preclinical models to evaluate ADC ocular toxicity